ライフサイエンスコーパス: arthroplasty

1 h risk for DVT (eg, recent total knee or hip arthroplasty).

2 e timing of orthopedic interventions such as arthroplasty.

3 ided hip pain, before and 9 months after hip arthroplasty.

4 e was obtained from patients undergoing knee arthroplasty.

5 tic events, in patients undergoing total hip arthroplasty.

6 within 2 years of diagnosis and 50% required arthroplasty.

7 as well as patients undergoing elective hip arthroplasty.

8 s and outcomes of joint surface collapse and arthroplasty.

9 ed to study the mortality outcomes following arthroplasty.

10 stoperative pain management after total knee arthroplasty.

11 undergoing hip or knee revision or resection arthroplasty.

12 ne was used in patients undergoing total hip arthroplasty.

13 tween minimal and standard incisions for hip arthroplasty.

14 and morbidity following elective knee or hip arthroplasty.

15 both inflammatory arthritis and total joint arthroplasty.

16 een ethnic groups are not seen following hip arthroplasty.

17 OA-affected joints at the time of total knee arthroplasty.

18 22, 95% CI 0.63-2.36 in Hispanics) after hip arthroplasty.

19 disc and are a viable option for total disc arthroplasty.

20 the trend of increasing rates of total knee arthroplasty.

21 uplex ultrasound approximately 1 month after arthroplasty.

22 boembolism in patients undergoing total knee arthroplasty.

23 ity in patients undergoing total hip or knee arthroplasty.

24 tion of infection associated with lower limb arthroplasty.

25 ts in the treatment group had undergone knee arthroplasty.

26 embolism within three months after total hip arthroplasty.

27 d from knees of patients who underwent joint arthroplasty.

28 period, in younger patients, and after joint arthroplasty.

29 ients who had previously undergone total hip arthroplasty.

30 rin for thromboprophylaxis after hip or knee arthroplasty.

31 g complications that hinder the merits of an arthroplasty.

32 enoxaparin in patients undergoing total knee arthroplasty.

33 factors for infection following total joint arthroplasty.

34 gnosis of invasive SSI following hip vs knee arthroplasty.

35 ollowing knee arthroplasty compared with hip arthroplasty.

36 on is a major complication after total joint arthroplasty.

37 l treatments to reduce pain after total knee arthroplasty.

38 association between statin exposure and knee arthroplasty.

39 with late infection of his right total knee arthroplasty.

40 ue culture obtained at revision or resection arthroplasty.

41 is the most frequent medical complication of arthroplasty.

42 asty and 0.26% (95% CI, 0.14%-0.37%) for hip arthroplasty.

43 y among patients after undergoing total knee arthroplasty.

44 asty and 0.14% (95% CI, 0.07%-0.21%) for hip arthroplasty.

45 and 348,596 who underwent revision total hip arthroplasty.

46 erably in the future along with the need for arthroplasties.

47 knee (HR 0.91 [95% CI 0.72-1.15], P = 0.41) arthroplasties.

48 dentified; 401 (61%) occurred following knee arthroplasties.

49 oth groups were cholecystectomy (10.5%), hip arthroplasty (10.5%), spine surgery (9.8%), herniorrhaph

50 hernia repair (26.5%), hysterectomy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypas

51 oups of patients: 14 who were undergoing hip arthroplasty, 28 hemodialysis patients who were particip

52 In patients who underwent total hip arthroplasty, a body-mass index of 25 or greater was ass

53 most dreaded complications after total joint arthroplasty, a common procedure in patients with rheuma

54 ough 2000 to determine the incidence of knee arthroplasty according to Hospital Referral Region, sex,

55 significantly shorter for hip than for knee arthroplasties after adjusting for age, pathogen virulen

56 there were 679 hip arthroplasties and 7 knee arthroplasties among centenarians in this database.

57 We describe the epidemiology of knee and hip arthroplasties among centenarians using data from a larg

58 here are large variations in the use of knee arthroplasty among Medicare enrollees according to race

59 udied epidemiology and mortality outcomes of arthroplasty among these individuals.

60 Overall, there were 679 hip arthroplasties and 7 knee arthroplasties among centenari

61 In particular, the frequencies of arthroplasties and arthrodeses of hand and foot joints w

62 is known to provoke aseptic loosening around arthroplasties and is associated with implant failures.

63 sm were 0.27% (95% CI, 0.16%-0.38%) for knee arthroplasty and 0.14% (95% CI, 0.07%-0.21%) for hip art

64 VT were 0.63% (95% CI, 0.47%-0.78%) for knee arthroplasty and 0.26% (95% CI, 0.14%-0.37%) for hip art

65 all 30-day mortality was 0.6% following knee arthroplasty and 0.7% following hip arthroplasty, with n

66 reased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001).

67 28 patients with proved infected total knee arthroplasty and 28 patients with noninfected arthroplas

68 eneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision total hi

69 , data on 12,108 patients who underwent knee arthroplasty and 6,703 patients who underwent hip arthro

70 further increased in the setting of revision arthroplasty and a previous prosthetic joint infection.

71 se thalamic volume changes reverse after hip arthroplasty and are associated with decreased pain and

72 ections are a devastating complication after arthroplasty and are associated with substantial patient

73 nous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge.

74 ophytic fibrocartilage were obtained at knee arthroplasty and cultured ex vivo with or without IL-1 b

75 observational data on the incidence of joint arthroplasty and disability will help to place the issue

76 e lesions in younger patients, none required arthroplasty and four improved.

77 om the tibial plateau of OA knees removed at arthroplasty and from normal, nonarthritic, knees obtain

78 ered by patient sex, with significantly more arthroplasty and fusion procedures performed in women.

79 ecting infections associated with lower limb arthroplasty and is more accurate for detecting infectio

80 s older than 10 years, 19 required total hip arthroplasty and none improved.

81 s, to guide the child and family through hip arthroplasty and rehabilitation.

82 ong patients undergoing elective hip or knee arthroplasty and treated with perioperative warfarin, ge

83 initiating warfarin for elective hip or knee arthroplasty and was conducted at 6 US medical centers.

84 on (range: 61% for TURP to 88% for total hip arthroplasty), and are thus missed by the ProPublica mea

85 osis surgery, embolic complications of joint arthroplasty, and complications related to the use of op

86 rom 4472 randomly selected cardiac, hip/knee arthroplasty, and hysterectomy cases.

87 as the use of bone morphogenic protein, disk arthroplasty, and interspinous spacers, are seen with in

88 aneurysm (AAA) repair, colectomy, total hip arthroplasty, and pancreatectomy.

89 The procedure codes for fusion, arthroplasty, and tenosynovectomy were matched to patien

90 More than 1 million arthroplasties are done every year worldwide, and this n

91 f infection-related complications after knee arthroplasty are higher in Hispanic patients than in whi

92 In the US population, hip and knee arthroplasty are very rarely performed among centenarian

93 ppeared more likely to be isolated as either arthroplasty-associated non-prosthetic joint infection-a

94 were icaA positive, and 30% (7 out of 23) of arthroplasty-associated non-prosthetic joint infection-a

95 tive staphylococci isolated from noninfected arthroplasty-associated specimens were screened in order

96 elihood of joint deterioration necessitating arthroplasty at a young age.

97 l spine fusion for myelopathy, or total knee arthroplasty at hospitals in California were abstracted

98 ts of both cemented and cementless total hip arthroplasty at mid- to long-term follow-up.

99 splay the time to joint surface collapse and arthroplasty based on selected predictors.

100 aries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease

101 ion codes for primary and revision total hip arthroplasty between 1991 and 2008.

102 s of invasive SSI was delayed following knee arthroplasty compared with hip arthroplasty.

103 fection-related complications following knee arthroplasty, compared with white patients.

104 Total hip arthroplasty continues to be an extremely successful pro

105 nical trials indicate that newer total ankle-arthroplasty designs provide substantial pain relief in

106 lex S. aureus SSIs decreased for hip or knee arthroplasties (difference per 10,000 operations, -17 [9

107 erived wear particles, recovered at revision arthroplasty, dose-dependently prompt TNF secretion by B

108 exercise participation prior to total joint arthroplasty dramatically reduces the odds of inpatient

109 Arthroplasties due to hip fracture were censored.

110 a for the study were indication for revision arthroplasty due to aseptic implant failure, acute high-

111 e been used in dental implants and total hip arthroplasty due to their excellent biocompatibility.

112 ption analgesic or antiinflammatory use, and arthroplasty during 1 year of followup.

113 ection (SSI) is a feared complication in hip arthroplasty, especially following femoral neck fracture

114 Future demand for hip arthroplasty, especially in patients younger than 65 yea

115 al joints, other surgical procedures such as arthroplasty, excision of painful calcinosis, and digita

116 ndergone a primary revision of a total elbow arthroplasty for aseptic loosening between 1996 and 2008

117 Risk-adjusted mortality estimates following arthroplasty for centenarians were higher than for nonag

118 All subjects had undergone total hip arthroplasty for idiopathic arthritis, and the scans wer

119 The utilization of joint arthroplasty for knee or hip osteoarthritis varies marke

120 radiographic finding of hip OA or total hip arthroplasty for OA (OR 1.71, 95% CI 1.16-2.52, P = 0.00

121 ing the use of ACSS in a 2-stage hip or knee arthroplasty for treatment of PJI (1988 through August 2

122 4.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001).

123 499 consecutive patients undergoing revision arthroplasty from whom 1,437 periprosthetic tissue sampl

124 hyperintense synovitis at MR imaging of knee arthroplasty had a high sensitivity and specificity for

125 Ethnic differences in use of arthroplasty have been associated with less willingness

126 ts in orthopedic surgery, the results of hip arthroplasty have improved.

127 -ceramic, and techniques such as resurfacing arthroplasty have the potential to improve outcomes and

128 Revision arthroplasty (hazard ratio [HR] 2.99, 95% confidence int

129 t the personal and societal expense of joint arthroplasty, hospitalizations, disability, and diminish

130 al group, conducted at 2 public, high-volume arthroplasty hospitals in Sydney, Australia (July 2012-D

131 borderline statistically significant for hip arthroplasty (HR 0.73 [95% CI 0.52-1.03], P = 0.07), and

132 therapy had significantly lower rates of any arthroplasty (HR 0.84 [95% CI 0.70-1.00], P = 0.05).

133 03], P = 0.07), and not significant for knee arthroplasty (HR 0.87 [95% CI 0.71-1.07], P = 0.19).

134 in trial, there was no association for total arthroplasty (HR 0.99 [95% CI 0.82-1.20], P = 0.92) or f

135 d no association between statin use and knee arthroplasty (HR, 1.04; 95% CI, .99-1.09).

136 ry types and was strongest after total joint arthroplasty (HR, 3.79; 95% CI, 3.21-4.47 for hip replac

137 issues from people with metal-on-polymer hip arthroplasties, immunohistochemically.

138 Twenty-three patients (29%) underwent arthroplasty in 36 hips at a mean of 1.3 years (range, 0

139 decrease in the rates of primary total knee arthroplasty in patients with RA.

140 te to the increased infection risk following arthroplasty in patients with T2D and obesity.

141 urgical diagnosis (hip fracture treated with arthroplasty) in 2010.

142 ge for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for r

143 to our knowledge, the first case of S. suis arthroplasty infection and streptococcal toxic shock-lik

144 Total hip arthroplasty is a common surgical procedure but little i

145 Total hip arthroplasty is a cost-effective surgical procedure unde

146 Cementless arthroplasty is a promising replacement strategy in adol

147 ve staphylococcal isolate associated with an arthroplasty is not a useful diagnostic indicator of pat

148 t rehabilitation after elective hip and knee arthroplasty is often necessary for patients who cannot

149 agatran started the morning after total knee arthroplasty is well tolerated and at least as effective

150 undergoing knee arthroscopy (ACL injury) or arthroplasty (late-stage primary OA) or in controls.

151 For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days

152 ear to differ significantly in terms of post-arthroplasty mortality rates.

153 matic venous thromboembolism after total hip arthroplasty most commonly develops after the patient is

154 to failed Metal-on-Polymer articulating hip arthroplasties (n = 10).

155 rgery (fracture groups, n = 33) or total hip arthroplasty (nonfracture groups, n = 17).

156 RA who required unilateral sialastic implant arthroplasty of the 2nd-5th metacarpophalangeal (MCP) jo

157 Arthroplasty of the knee and hip have been successful in

158 with prednisone or methotrexate (n = 34), or arthroplasty of the knee or hip (n = 28).

159 ecision and choice of antibiotics in routine arthroplasties or PJI's.

160 ed as a pathogen in foreign-body infections (arthroplasty or spinal instrumentation).

161 lished race/ethnicity-specific data on joint arthroplasty outcomes.

162 oplasty and 6,703 patients who underwent hip arthroplasty over a 5-year period were analyzed.

163 lgesic or antiinflammatory drugs, and having arthroplasty (P < 0.001).

164 r antiinflammatory use but decreased odds of arthroplasty (P < 0.01).

165 The proportion of primary total hip arthroplasty patients discharged home declined from 68.0

166 hrombocytopenia: one following shoulder hemi-arthroplasty (performed without heparin) and the other p

167 ion for cervical spine surgery or total knee arthroplasty (primary and revision), although in 1998-20

168 Advances concerning bone grafting and arthroplasty procedures have resulted in improved clinic

169 ived for bacterial culture from 198 revision arthroplasty procedures, we retrospectively determined t

170 s, including cardiac bypass and hip and knee arthroplasty procedures.

171 onitored home-based program after total knee arthroplasty provided greater improvements than a monito

172 tributed to racial and ethnic disparities in arthroplasty rates.

173 llograft bone donated from primary total hip arthroplasty recipients must be discarded or treated to

174 A vast majority (83%) of hip arthroplasty recipients were women.

175 Osteolysis complicating arthroplasty reflects progressive generation of implant-

176 ening urine cultures prior to elective joint arthroplasty resulted in substantial reduction in urine

177 One hundred thirty-six patients undergoing arthroplasty revision or resection were studied; 33 had

178 f infection-related complications after knee arthroplasty (RR 1.64, 95% CI 1.08-2.49) relative to oth

179 tic joint prosthesis loosening (septic total arthroplasty [SeTA]; 9 specimens), rheumatoid arthritis

180 orefoot, metatarsophalangeal joint resection arthroplasty shortens the lever arm of the foot, defunct

181 Our in-hospital mortality data suggest that arthroplasties should not be denied to centenarians sole

182 The newer cementless hip arthroplasties showed evidence of learning curve, partic

183 For revision total hip arthroplasty, similar trends were observed in hospital L

184 ces made by the silicone metacarpophalangeal arthroplasty (SMPA) group regarding hand reconstruction

185 rom tissue donors and OA cartilage from knee arthroplasty specimens.

186 Exercise participation prior to total joint arthroplasty substantially reduced the risk of discharge

187 w of 0.005 for "Procedure-Targeted Total Hip Arthroplasty Surgical Site Infection." Generally, reliab

188 ports the safety and efficacy of total-ankle arthroplasty (TAA).

189 parameters and the 19-year risk of total hip arthroplasty (THA) for end-stage OA.

190 ing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the facto

191 predictors of prognosis following total hip arthroplasty (THA) for osteoarthritis (OA).

192 -day readmission to hospital after total hip arthroplasty (THA) has significant direct costs and is u

193 spirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial.

194 of 108 men and women scheduled for total hip arthroplasty (THA) or total knee arthroplasty (TKA) were

195 itals' SSI rates following primary total hip arthroplasty (THA) or total knee arthroplasty (TKA).

196 slocation and aseptic loosening in total hip arthroplasty (THA).

197 n muscle of patients who were undergoing hip arthroplasty, the 14-kD actin fragment level was correla

198 g adults undergoing uncomplicated total knee arthroplasty, the use of inpatient rehabilitation compar

199 Although total joint arthroplasty (TJA) is a common procedure and an importan

200 25% of RA patients will undergo total joint arthroplasty (TJA) within 21.8 years of disease onset.

201 xplain disparities in the use of total joint arthroplasty (TJA).

202 udies on rehabilitation following total knee arthroplasty (TKA) demonstrated limited efficacy in incr

203 Total knee arthroplasty (TKA) is one of the most common and costly

204 Total knee arthroplasty (TKA) is one of the most successful orthopa

205 provides convincing evidence that total knee arthroplasty (TKA) is safe and improves joint-specific o

206 ugh frequently observed following total knee arthroplasty (TKA) no therapeutic options exist.

207 r total hip arthroplasty (THA) or total knee arthroplasty (TKA) were randomized to a 6-week exercise

208 ynovial patterns in patients with total knee arthroplasty (TKA), whether diagnostic accuracy differs

209 en used for local infiltration in total knee arthroplasty (TKA).

210 nal trends in the epidemiology of total knee arthroplasty (TKA).

211 odel of surgery-induced fibrosis, total knee arthroplasty (TKA).

212 y total hip arthroplasty (THA) or total knee arthroplasty (TKA).

213 . adults are projected to undergo total knee arthroplasty (TKA).

214 s from assessment (range: 42% for total knee arthroplasty to 96% for laparoscopic cholecystectomy).

215 going elective primary unilateral total knee arthroplasty to receive one of two doses of FXI-ASO (200

216 plasty (TPKA) and after total or partial hip arthroplasty (TPHA) are proposed patient safety indicato

217 boembolism (VTE) after total or partial knee arthroplasty (TPKA) and after total or partial hip arthr

218 idemiology and utilization of total shoulder arthroplasty (TSA) have not been previously reported.

219 vs 42 days (IQR, 21-114 days) following knee arthroplasty (unadjusted hazard ratio [HR], 1.60; 95% co

220 ilms dislodged from the surface of explanted arthroplasties using vortexing and sonication (i.e., son

221 y 2005 to August 2009, including colorectal, arthroplasty, vascular, and gynecologic procedures.

222 proctectomy, hysterectomy, total hip or knee arthroplasty, ventral hernia repair, and lower extremity

223 rtile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following kne

224 Median age at time of first arthroplasty was 20.1 years (range, 15.1 to 35.4 years).

225 going elective primary unilateral total knee arthroplasty was an effective method for its prevention

226 the national level, the annual rate of knee arthroplasty was higher for non-Hispanic white women (5.

227 sk of hospitalization for primary total knee arthroplasty was significantly lower in 1998-2001 than i

228 Overall, 23 (3.7%) joint arthroplasties were complicated by an infection during a

229 Participants reported hospitalizations, and arthroplasties were identified by procedure codes.

230 A total of 430,726 knee arthroplasties were performed during the three-year stud

231 ctrotherapy and acupuncture after total knee arthroplasty were associated with reduced and delayed op

232 Women with prior arthroplasty were excluded, yielding a sample size of 26

233 Rates of total knee or hip arthroplasty were found to be substantially lower among

234 d infection-related complications after knee arthroplasty were higher among black patients compared w

235 ents scheduled to undergo elective total hip arthroplasty were randomly assigned, stratified accordin

236 rthroplasty and 28 patients with noninfected arthroplasty were reviewed by two musculoskeletal radiol

237 Candidates for total hip or total knee arthroplasty were reviewed in a multicenter cohort study

238 osteoarthritis undergoing primary total knee arthroplasty were screened for eligibility.

239 cystectomy, partial colectomy, and total hip arthroplasty were used.

240 of the reconstructive procedures-fusion and arthroplasty-were highly correlated in each state, but t

241 iewed in a cohort of 58 patients with 66 hip arthroplasties with Rejuvenate stems who had presented f

242 t and retention of the prosthesis, resection arthroplasty with or without subsequent staged reimplant

243 rgery with post-operative rehabilitation, or arthroplasty with post-operative rehabilitation.

244 ing knee arthroplasty and 0.7% following hip arthroplasty, with no significant differences by race/et